GENEVA, Sept. 7 -- CF PHARMTECH, INC. filed a patent application (CN2026/080047) for “SIRNA FOR INHIBITING TSLP, AND MODIFIED FORM AND USE THEREOF”. With publication no. WO/2026/179900, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....